Skip to main content
. 2004 Aug;48(8):3043–3050. doi: 10.1128/AAC.48.8.3043-3050.2004

FIG. 6.

FIG. 6.

Efficacies of telavancin, vancomycin, and linezolid against MRSA 33591 in the mouse neutropenic thigh model. The abscissa shows the total 24-h dosage, and the ordinate shows the titer observed in thighs. Vehicle (n = 16) and telavancin (n = 5 to 16 per dose) were administered q 24 h, whereas vancomycin (n = 5 per dose) and linezolid (n = 6 per dose) were administered q 12 h. n = 16 for the control pretreatment group. Data are expressed as means ± 1 SD (error bars).